Abstract
From evidence based on the use of specific receptor subtype antagonists, it has generally been assumed that human uterine tissue contains only type 2 (AT2) angiotensin II (All) receptor subtype. Using a monoclonal antibody, 6313/G2, directed against a specific sequence in the extracellular domain of the type 1 All receptor (AT1), in immunocytochemical studies, we show here that AT1 receptor is expressed in human endometrium. In particular, positive staining was seen in the endometrial glandular epithelium, and in the vascular endothelium, while the myometrium and endometrial stroma were negative. The most intense staining was observed during the late proliferative phase and less in the luteal phase. The ligand binding assay, using [125I]-angiotensin II, revealed high concentrations of All receptors both in the endometrium and in the myometrium. Competition studies using losartan (AT1 specific) and CGP42112B (AT2 specific) showed that both AT1 and AT2 receptor subtypes were present in the endometrium, though only the AT2 receptor subtype was detected in the myometrium. Immunoblotting confirmed that the antibody 6313/G2 detected a single protein with a molecular weight of ∼60 kDa. These data clearly demonstrate the presence of endometrial AT1 receptors whose expression appears to be under hormonal control. © European Society for Human Reproduction and Embryology.
Author supplied keywords
Cite
CITATION STYLE
Saridogan, E., Djahanbakhch, O., Puddefoot, J. R., Demetroulis, C., Dawda, R., Hall, A. J., & Vinson, G. P. (1996). Type 1 angiotensin II receptors in human endometrium. Molecular Human Reproduction, 2(9), 659–664. https://doi.org/10.1093/molehr/2.9.659
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.